Stock Track | Agios Pharmaceuticals Soars 6.07% in Pre-Market on Strong Q1 Earnings Beat

Stock Track

Apr 29

Agios Pharmaceuticals' stock surged 6.07% in pre-market trading on Wednesday after the company reported first-quarter financial results that significantly exceeded analyst expectations.

The biopharmaceutical firm posted a quarterly loss of $1.69 per share, which was better than the consensus estimate for a loss of $1.79 per share. More notably, revenue for the quarter reached $20.75 million, more than doubling from the same period last year and beating the average analyst estimate of approximately $13.6 million by a wide margin.

The strong revenue performance was primarily driven by the successful U.S. commercial launch of its drug AQVESME (mitapivat) for thalassemia in late January 2026, along with continued demand for its product PYRUKYND in international markets.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1179207525"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1179207525\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1179207525?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-29 21:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179207525","market":"sg","top_or_hot":-1,"title":"Stock Track | Agios Pharmaceuticals Soars 6.07% in Pre-Market on Strong Q1 Earnings Beat","media":"Stock Track","content":"<p>Agios Pharmaceuticals' stock surged 6.07% in pre-market trading on Wednesday after the company reported first-quarter financial results that significantly exceeded analyst expectations.</p><p>The biopharmaceutical firm posted a quarterly loss of $1.69 per share, which was better than the consensus estimate for a loss of $1.79 per share. More notably, revenue for the quarter reached $20.75 million, more than doubling from the same period last year and beating the average analyst estimate of approximately $13.6 million by a wide margin.</p><p>The strong revenue performance was primarily driven by the successful U.S. commercial launch of its drug AQVESME (mitapivat) for thalassemia in late January 2026, along with continued demand for its product PYRUKYND in international markets.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Agios Pharmaceuticals Soars 6.07% in Pre-Market on Strong Q1 Earnings Beat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Agios Pharmaceuticals Soars 6.07% in Pre-Market on Strong Q1 Earnings Beat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-29 21:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Agios Pharmaceuticals' stock surged 6.07% in pre-market trading on Wednesday after the company reported first-quarter financial results that significantly exceeded analyst expectations.</p><p>The biopharmaceutical firm posted a quarterly loss of $1.69 per share, which was better than the consensus estimate for a loss of $1.79 per share. More notably, revenue for the quarter reached $20.75 million, more than doubling from the same period last year and beating the average analyst estimate of approximately $13.6 million by a wide margin.</p><p>The strong revenue performance was primarily driven by the successful U.S. commercial launch of its drug AQVESME (mitapivat) for thalassemia in late January 2026, along with continued demand for its product PYRUKYND in international markets.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AGIO","symbol_name":"Agios Pharmaceuticals, Inc.","start_time":0,"source_url":"","article_id":"1179207525","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179207525","pubTimestamp":1777468609,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Agios Pharmaceuticals' stock surged 6.07% in pre-market trading on Wednesday after the company reported first-quarter financial results that significantly exceeded analyst expectations.The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AGIO":"Agios Pharmaceuticals, Inc."},"translate_title":"个股追踪|Agios Pharmaceuticals盘前飙升6.07%因Q1盈利强劲","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AGIO":1},"content_text":"Agios Pharmaceuticals' stock surged 6.07% in pre-market trading on Wednesday after the company reported first-quarter financial results that significantly exceeded analyst expectations.The biopharmaceutical firm posted a quarterly loss of $1.69 per share, which was better than the consensus estimate for a loss of $1.79 per share. More notably, revenue for the quarter reached $20.75 million, more than doubling from the same period last year and beating the average analyst estimate of approximately $13.6 million by a wide margin.The strong revenue performance was primarily driven by the successful U.S. commercial launch of its drug AQVESME (mitapivat) for thalassemia in late January 2026, along with continued demand for its product PYRUKYND in international markets.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}